Apollomics, Inc.透過任命重要職位以增強領導能力
22 janv. 2019 07h50 HE
|
CBT Pharmaceuticals
Wilson W. Cheung，CPA獲任命為財務總監Debra L. Thoma Vallner博士，工商管理碩士，獲任命為開發營運部高級副總裁 加利福尼亞州福斯特城和中國杭州, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Apollomics, Inc.是一家致力發現和開發腫瘤組合療法的創新型生物製藥公司，今天宣布任命Wilson W....
Apollomics, Inc. Strengthens Leadership with Key Hires
22 janv. 2019 07h50 HE
|
Apollomics, Inc.
Wilson W. Cheung, CPA appointed Chief Financial OfficerDebra L. Thoma Vallner, PhD, MBA named Senior Vice President, Development Operations FOSTER CITY, Calif. and HANGZHOU, China, Jan. 22, 2019 ...
创新生物制药公司Apollomics完成1亿美元融资
07 janv. 2019 07h50 HE
|
CBT Pharmaceuticals
FOSTER CITY, Calif. and HANGZHOU, China, Jan. 07, 2019 (GLOBE NEWSWIRE) --...
Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing
07 janv. 2019 07h50 HE
|
CBT Pharmaceuticals
Financing will accelerate development of the Company’s cancer immunotherapy and targeted therapy programs New brand reinforces Apollomics’ mission to discover and develop novel medicines and...
CBT Pharmaceuticals與Strata Oncology宣佈合作以加快CBT-101的研發。CBT-101是一種高度選擇性的c-Met抑制劑，用於治療非小細胞肺癌及其他實體腫瘤患者
10 déc. 2018 07h50 HE
|
CBT Pharmaceuticals
美國加利福尼亞州普萊森頓、中國杭州以及美國密歇根州安娜堡, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT) 是一間在中美兩國均設有辦事處的創新醫藥公司，而Strata...
CBT Pharmaceuticals和Strata Oncology宣布合作以加快CBT-101的研发。CBT-101是一种高度选择性的c-Met抑制剂，用于治疗非小细胞肺癌及其他实体肿瘤患者
10 déc. 2018 07h50 HE
|
CBT Pharmaceuticals
美国加利福尼亚州普莱森顿、中国杭州以及美国密歇根州安娜堡, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc. 是一家在中美两国均设有总部的创新医药公司，而Strata Oncology, Inc....
CBT Pharmaceuticals and Strata Oncology Announce Collaboration to Accelerate Development of CBT-101, a c-Met inhibitor, for Patients with Non-Small Cell Lung Cancer and other Solid Tumors
10 déc. 2018 07h50 HE
|
CBT Pharmaceuticals
PLEASANTON, Calif., HANGZHOU, China and ANN ARBOR, Mich., Dec. 10, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), Inc., a U.S. and China-based innovative pharmaceutical company, and Strata...
CBT Pharmaceuticals和Zhejiang Bossan Pharmaceutical簽訂合作和授權協議，共同研發癌症複合療法
26 nov. 2018 07h50 HE
|
CBT Pharmaceuticals
美國加州普萊森頓和中國杭州, Nov. 26, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals（CBT）和Zhejiang Bossan Pharmaceutical Co., Ltd...
CBT Pharmaceuticals（浙江冠科美博）和浙江博生医药有限公司签订合作和许可协议，共同研发癌症联合疗法
26 nov. 2018 07h50 HE
|
CBT Pharmaceuticals
美国加利福尼亚州普莱森顿和中国杭州, Nov. 26, 2018 (GLOBE NEWSWIRE) -- CBT...
CBT Pharmaceuticals and Zhejiang Bossan Pharmaceutical Enter into a Collaboration and License Agreement to Develop Combination Cancer Treatments
26 nov. 2018 07h50 HE
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, China, Nov. 26, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) today announced that they have entered into a...